Measuring value: pharmacoeconomics in theory and practice

Abstract

In ‘Measuring value with pharmacoeconomics’, the authors outline the evolution of cost-effectiveness analysis (CEA) through its use as part of HTA. They also explore the theoretical and practical issues that have arisen as the result of using CEA of drugs to make decisions about resource allocation, pricing and use. Recommendations are offered for addressing some of the critical challenges discussed